DZ3079A1 - Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé. - Google Patents

Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.

Info

Publication number
DZ3079A1
DZ3079A1 DZ000153A DZ000153A DZ3079A1 DZ 3079 A1 DZ3079 A1 DZ 3079A1 DZ 000153 A DZ000153 A DZ 000153A DZ 000153 A DZ000153 A DZ 000153A DZ 3079 A1 DZ3079 A1 DZ 3079A1
Authority
DZ
Algeria
Prior art keywords
tetrahydroquinole
carboxy
amino
substituted
preparation
Prior art date
Application number
DZ000153A
Other languages
English (en)
Inventor
David Burns Damon
Robert Wayne Dugger
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ3079A1 publication Critical patent/DZ3079A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DZ000153A 1999-11-30 2000-11-29 Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé. DZ3079A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16796799P 1999-11-30 1999-11-30

Publications (1)

Publication Number Publication Date
DZ3079A1 true DZ3079A1 (fr) 2004-10-24

Family

ID=22609556

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000153A DZ3079A1 (fr) 1999-11-30 2000-11-29 Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.

Country Status (44)

Country Link
US (1) US6313142B1 (fr)
EP (1) EP1125929B1 (fr)
JP (1) JP3579345B2 (fr)
KR (1) KR100408177B1 (fr)
CN (1) CN1173953C (fr)
AP (1) AP2000002011A0 (fr)
AR (1) AR029775A1 (fr)
AT (1) ATE315028T1 (fr)
AU (1) AU784694B2 (fr)
BG (1) BG105009A (fr)
BR (1) BR0005636A (fr)
CA (1) CA2327029C (fr)
CO (1) CO5261552A1 (fr)
CY (1) CY1104989T1 (fr)
CZ (1) CZ20004407A3 (fr)
DE (1) DE60025317T2 (fr)
DK (1) DK1125929T3 (fr)
DZ (1) DZ3079A1 (fr)
EA (1) EA003668B1 (fr)
EE (1) EE200000659A (fr)
ES (1) ES2254109T3 (fr)
GE (1) GEP20022798B (fr)
GT (1) GT200000190A (fr)
HN (1) HN2000000203A (fr)
HR (1) HRP20000804A2 (fr)
HU (1) HUP0004747A3 (fr)
ID (1) ID28489A (fr)
IL (1) IL139849A (fr)
IS (1) IS5715A (fr)
MA (1) MA25223A1 (fr)
NO (1) NO20006039L (fr)
NZ (1) NZ508509A (fr)
OA (1) OA11494A (fr)
PA (1) PA8503801A1 (fr)
PE (1) PE20010913A1 (fr)
PL (1) PL344208A1 (fr)
SG (1) SG102603A1 (fr)
SK (1) SK17792000A3 (fr)
TN (1) TNSN00230A1 (fr)
TW (1) TW591016B (fr)
UA (1) UA65615C2 (fr)
UY (1) UY26451A1 (fr)
YU (1) YU71500A (fr)
ZA (1) ZA200006947B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
MXPA04005864A (es) * 2001-12-19 2004-10-29 Atherogenics Inc Derivados de charcona y su uso para tratar enfermedades.
WO2003053359A2 (fr) 2001-12-19 2003-07-03 Atherogenics, Inc. 1,3-bis-(phenyl-substitue)-2-propyne-1-ones et leur utilisation pour le traitement d'affections
CA2480439C (fr) * 2002-04-11 2012-08-21 Roar Holding Llc Procede ex vivo permettant de determiner l'activite de cetp et l'efficacite d'un traitement d'une cardiopathie
US7504508B2 (en) * 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US20090181966A1 (en) * 2002-10-04 2009-07-16 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
MXPA05003456A (es) * 2002-10-04 2005-07-05 Millennium Pharm Inc Antagonistas del receptor de pgd2 para el tratamiento de enfermedades inflamatorias.
US7223870B2 (en) * 2002-11-01 2007-05-29 Pfizer Inc. Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
AU2003303239A1 (en) * 2002-12-19 2004-07-14 Atherogenics, Inc. Process of making chalcone derivatives
ATE407670T1 (de) 2002-12-20 2008-09-15 Pfizer Prod Inc Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
EP1601655A2 (fr) * 2003-03-04 2005-12-07 Takasago International Corporation Procede de production d'amines optiquement actives
CA2519458A1 (fr) * 2003-03-17 2004-09-30 Japan Tobacco Inc. Procede pour accroitre la biodisponibilite orale de s- 2-( '1-(2-ethylbutyl)cyclohexyl!carbonyl!amino)phenyl!-2-methylpropanethioate
PL1603553T3 (pl) * 2003-03-17 2012-04-30 Japan Tobacco Inc Kompozycje farmaceutyczne inhibitorów CETP
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
BRPI0414186A (pt) * 2003-10-08 2006-10-31 Lilly Co Eli compostos, métodos de antagonizar a atividade de cetp, de tratar ou prevenir uma doença, de diminuir o colesterol ldl plasmático em um mamìmero, de tratar e/ou prevenir seqüelas patológicas, formulação farmacêutica, e, uso de um composto
UA90269C2 (ru) * 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Тетрагидрохинолиновые производные и способ их получения
CA2570688A1 (fr) * 2004-06-24 2006-02-02 Eli Lilly And Company Composes et procedes destines a traiter la dyslipidemie
DOP2005000123A (es) * 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
WO2006033001A1 (fr) * 2004-09-23 2006-03-30 Pfizer Products Inc. Composes de quinoline
US7700774B2 (en) * 2004-12-20 2010-04-20 Dr. Reddy's Laboratories Ltd. Heterocyclic compounds and their pharmaceutical compositions
AU2006216713A1 (en) * 2005-02-24 2006-08-31 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
TW200808731A (en) 2006-03-30 2008-02-16 Tanabe Seiyaku Co A process for preparing tetrahydroquinoline derivatives
AR065670A1 (es) 2007-03-09 2009-06-24 Indigene Pharmaceuticals Inc Combinacion de metformina r-(+) lipoato y agentes antihiperlipidemicos para el tratamiento de hiperglucemia diabetica y complicaciones diabeticas
CN101429160B (zh) * 2007-11-06 2011-10-19 上海药明康德新药开发有限公司 一种1-r-4-氨基-1,2,3,4-四氢喹啉的合成方法
TWI450896B (zh) * 2009-06-30 2014-09-01 Lilly Co Eli 反式－４－〔〔（５ｓ）－５－〔〔〔３，５－雙（三氟甲基）苯基〕甲基〕（２－甲基－２ｈ－四唑－５－基）胺基〕－２，３，４，５－四氫－７，９－二甲基－１ｈ－１－苯并氮呯－１－基〕甲基〕－環己基羧酸
MA71399A (fr) 2022-07-05 2025-04-30 Newamsterdam Pharma B.V. Sels d'obicetrapib et leurs procédé de fabrication et leurs intermédiaires

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7870M (fr) * 1968-11-08 1970-04-27
US3971789A (en) 1972-10-21 1976-07-27 John Wyeth & Brother Limited O-(4-Quinolylamino)benzamides
GB8432091D0 (en) 1984-12-19 1985-01-30 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
US4839368A (en) 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
GB8804444D0 (en) 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5231102A (en) 1989-03-08 1993-07-27 Merck Sharp & Dohme, Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6140342A (en) 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6147089A (en) 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.

Also Published As

Publication number Publication date
NZ508509A (en) 2001-06-29
PA8503801A1 (es) 2002-07-30
EE200000659A (et) 2001-08-15
CA2327029A1 (fr) 2001-05-30
IL139849A0 (en) 2002-02-10
CZ20004407A3 (cs) 2002-06-12
HN2000000203A (es) 2001-06-13
GEP20022798B (en) 2002-09-25
HU0004747D0 (fr) 2001-02-28
EP1125929A1 (fr) 2001-08-22
CO5261552A1 (es) 2003-03-31
CA2327029C (fr) 2005-08-09
NO20006039D0 (no) 2000-11-29
YU71500A (sh) 2003-02-28
DE60025317T2 (de) 2006-08-03
SG102603A1 (en) 2004-03-26
KR100408177B1 (ko) 2003-12-01
US6313142B1 (en) 2001-11-06
EP1125929B1 (fr) 2006-01-04
EA003668B1 (ru) 2003-08-28
DK1125929T3 (da) 2006-04-03
TNSN00230A1 (fr) 2005-11-10
PE20010913A1 (es) 2001-09-10
JP2001163859A (ja) 2001-06-19
ID28489A (id) 2001-05-31
ATE315028T1 (de) 2006-02-15
SK17792000A3 (sk) 2002-10-08
HUP0004747A2 (hu) 2001-10-28
AU7178900A (en) 2001-05-31
KR20010052012A (ko) 2001-06-25
HK1038007A1 (en) 2002-03-01
CN1173953C (zh) 2004-11-03
UY26451A1 (es) 2001-06-29
IL139849A (en) 2006-10-31
BR0005636A (pt) 2001-07-17
TW591016B (en) 2004-06-11
GT200000190A (es) 2002-04-27
OA11494A (en) 2004-05-07
MA25223A1 (fr) 2001-07-02
AU784694B2 (en) 2006-06-01
CY1104989T1 (el) 2010-03-03
EA200001129A2 (ru) 2001-06-25
PL344208A1 (en) 2001-06-04
UA65615C2 (uk) 2004-04-15
NO20006039L (no) 2001-05-31
IS5715A (is) 2001-05-31
HRP20000804A2 (en) 2001-06-30
AP2000002011A0 (en) 2000-12-31
HUP0004747A3 (en) 2002-12-28
ES2254109T3 (es) 2006-06-16
EA200001129A3 (ru) 2001-10-22
BG105009A (en) 2001-11-30
ZA200006947B (en) 2002-05-27
DE60025317D1 (de) 2006-03-30
CN1302800A (zh) 2001-07-11
JP3579345B2 (ja) 2004-10-20
AR029775A1 (es) 2003-07-16

Similar Documents

Publication Publication Date Title
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
DZ2247A1 (fr) Procédé pour la préparation du sildénafil.
MA25493A1 (fr) Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
ZA200106721B (en) Process for the manufacture of furfural.
DZ2114A1 (fr) Procédé pour la préparation du d-tartrate de (-)-cis-6(s)-phényl-5}4-(2-pyrrolidine-1-ylethoxy)-phénylÜ-5,6,7,8-tétrahydronaphtalène-2-ol.
DZ2912A1 (fr) Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé.
MA24182A1 (fr) Procede pour la preparation de 2,4-diaminopyrimidines substituees
EP0671206A3 (fr) Procédé de préparation de microcapsules.
DZ1946A1 (fr) Procédé pour la préparation de supports.
EP1023250A4 (fr) Procede de preparation de 2,6-dialkylnaphtalene
EP0669363A3 (fr) Procédé de préparation de polyorganosilane.
FR2721598B1 (fr) Procédé de préparation de catalyseurs d'ammoxydation.
DZ2430A1 (fr) Procédé pour la préparation de dérivés de thiazolidinedione substitués.
DZ2607A1 (fr) Procédé pour la synthése de dérivés de quinoléine pharmaceutiquement actifs.
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
NO20005424D0 (no) FremgangsmÕte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
DZ3018A1 (fr) Procédés perfectionnés pour la préparation sécrétagogues d'hormones de croissance.
DZ3096A1 (fr) Procédé pour la préparation de dérivés de pyrazoloÄ4,3-DÜpyrimidine-7-one-3-pyridylsulfonyle, et intermédiaires utilisés.
DZ2746A1 (fr) Nouveau procédé de préparation de la fexofénadine.
DZ2770A1 (fr) Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
DZ2757A1 (fr) Procédé pour la préparation d'acides hydroxamiques.
EP0610963A3 (fr) Procédé pour la préparation de 1,1,1,2-tétrafluoroéthane.
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
NO20005425D0 (no) FremgangsmÕte ved fremstilling av 1,3-disubstituert-4- oksocykliske ureaer
EP1295864A4 (fr) Procede de preparation de 1,5-diaminonaphtalenes